Dr. Peng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
8700 Beverly Blvd
Los Angeles, CA 90048Phone+1 310-423-2641Fax+1 310-423-4678
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Nephrology, 1998 - 2001- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Internal Medicine, 1995 - 1998
David Geffen School of Medicine at UCLAClass of 1995
Certifications & Licensure
CA State Medical License 1997 - 2026- American Board of Internal Medicine Nephrology
Clinical Trials
- C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI Start of enrollment: 2014 Sep 01
- Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients Start of enrollment: 2023 Apr 10
Roles: Sub-Investigator, Contact
Publications & Presentations
PubMed
- 10 citationsAn Assessment of the Value of Donor-derived Cell-free DNA Surveillance in Patients With Preserved Kidney Allograft Function.Edmund Huang, Mark Haas, Matt Gillespie, Supreet Sethi, Alice Peng
Transplantation. 2023-01-01 - 14 citationsA Banff-based histologic chronicity index is associated with graft loss in patients with a kidney transplant and antibody-mediated rejection.Mark Haas, James Mirocha, Edmund Huang, Reiad Najjar, Alice Peng
Kidney International. 2023-01-01 - 23 citationsClazakizumab for desensitization in highly sensitized patients awaiting transplantation.Ashley A Vo, Edmund Huang, Noriko Ammerman, Mieko Toyoda, Shili Ge
American Journal of Transplantation. 2022-04-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
